Search hospitals > Nova Scotia > HALIFAX

IWK Health Centre

Claim this profile
HALIFAX, Nova Scotia B3K 6R8
Global Leader in Leukemia
Global Leader in Lymphoblastic Leukemia-Lymphoma
Conducts research for Tumors
Conducts research for Sarcoma
Conducts research for Brain Tumor
311 reported clinical trials
11 medical researchers
Photo of IWK Health Centre in HALIFAXPhoto of IWK Health Centre in HALIFAXPhoto of IWK Health Centre in HALIFAX

Summary

IWK Health Centre is a medical facility located in HALIFAX, Nova Scotia. This center is recognized for care of Leukemia, Lymphoblastic Leukemia-Lymphoma, Tumors, Sarcoma, Brain Tumor and other specialties. IWK Health Centre is involved with conducting 311 clinical trials across 486 conditions. There are 11 research doctors associated with this hospital, such as Craig Erker, Jennifer Foster, MD, Adam Huber, MD, and Anthony Otley.

Area of expertise

1Leukemia
Global Leader
IWK Health Centre has run 58 trials for Leukemia. Some of their research focus areas include:
Stage II
NTRK1 positive
NTRK positive
2Lymphoblastic Leukemia-Lymphoma
Global Leader
IWK Health Centre has run 36 trials for Lymphoblastic Leukemia-Lymphoma. Some of their research focus areas include:
Stage II
BCR-ABL1 fusion positive
ABL-class fusion positive

Top PIs

Clinical Trials running at IWK Health Centre

Astrocytoma
Ulcerative Colitis
Ovarian Tumors
Acute Lymphoblastic Leukemia
Low Grade Glioma
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Brain Tumor
Crohn's Disease
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Image of trial facility.

Selumetinib + Vinblastine

for Low-Grade Glioma

This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Image of trial facility.

Selinexor + Radiation

for Brain Cancer

This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at IWK Health Centre?
IWK Health Centre is a medical facility located in HALIFAX, Nova Scotia. This center is recognized for care of Leukemia, Lymphoblastic Leukemia-Lymphoma, Tumors, Sarcoma, Brain Tumor and other specialties. IWK Health Centre is involved with conducting 311 clinical trials across 486 conditions. There are 11 research doctors associated with this hospital, such as Craig Erker, Jennifer Foster, MD, Adam Huber, MD, and Anthony Otley.
Where is IWK Health Centre located?
The IWK Health Centre is located at 5980 University Ave, Halifax, NS B3K 0B4, Canada.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at IWK Health Centre, please visit their official website and use the "Contact Us" form for detailed information. For bill payments and related inquiries, contact Nova Scotia Health through their centralized contact options.
What insurance does IWK Health Centre accept?
The IWK Health Centre accepts various insurance plans, including those from Nova Scotia's Health Insurance Programs and other provincial health plans for residents of Canadian provinces. These programs cover a wide range of services such as hospital visits and stays, doctor visits, medically necessary dental and optometric services, and more. Employees of the IWK Health Centre have access to mandatory benefits like basic life insurance, long-term disability, and pension through NSHEPP, with optional benefits available.
What awards or recognition has IWK Health Centre received?
The IWK Health Centre in Halifax, Nova Scotia, is primarily funded by government sources for its operational costs. It also benefits from donations made to the IWK Foundation, which support the purchase of specialized equipment and research initiatives. In 2022, the IWK Foundation contributed $5,427 in cash donations, with an additional $1,704 receivable.